Options
Post-HSCT graft failure due to refractory human cytomegalovirus successfully treated with haploidentical donor-derived immunoglobulins and stem cell graft infusion
Journal
ANTIVIRAL RESEARCH
ISSN
0166-3542
Author(s)
DOI
10.1016/j.antiviral.2021.105024